Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) is a publicly traded Healthcare sector company. As of November 3, 2026, RYTM trades at $93.57 with a market cap of $6.37B and a P/E ratio of -30.10. RYTM moved +1.10% today. Year to date, RYTM is -10.90%; over the trailing twelve months it is -17.76%. Its 52-week range spans $45.91 to $122.20. Analyst consensus is strong buy with an average price target of $146.39. Rallies surfaces RYTM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
RYTM financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. RYTM recently traded at $93.57. Market cap is $6.37B. P/E ratio is -30.10. Revenue is $239.92M.
| Metric | Value |
|---|---|
| Price | $93.57 |
| Market Cap | $6.37B |
| P/E Ratio | -30.10 |
| EPS | $-3.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $122.20 |
| 52-Week Low | $45.91 |
| Volume | 1.40M |
| Avg Volume | 0 |
| Revenue (TTM) | $239.92M |
| Net Income | $-205.35M |
| Gross Margin | 89.00% |
15 analysts cover RYTM: 0 strong buy, 14 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $146.39.